BTAI BioXcel Therapeutics, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $0 and sold $43.2K on the open market.
Recent BTAI insider trades
- May 20, 2026: Mehta Vimal sold 19,419 shares ($21.2K)
- May 20, 2026: Steinhart Richard I sold 6,845 shares ($7.46K)
- May 20, 2026: Rodriguez Javier sold 6,560 shares ($7.09K)
- May 20, 2026: Yocca Frank sold 6,845 shares ($7.46K)
5%+ owners
- Millennium Management LLC: 8.4% (Schedule 13G/A, filed Feb 9, 2026)